L3VLUP
ProSign in

ICUI · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ICUILLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ICUI
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterICUILLY
Q3 202012 holders, $1.1bn33 holders, $14.1bn
Q4 202010 holders, $1.2bn29 holders, $17.3bn
Q1 20219 holders, $1.2bn24 holders, $23.0bn
Q2 20219 holders, $1.1bn24 holders, $27.8bn
Q3 202111 holders, $1.3bn31 holders, $29.9bn
Q4 202111 holders, $1.7bn31 holders, $34.7bn
Q1 20227 holders, $1.6bn24 holders, $35.3bn
Q2 20229 holders, $1.2bn33 holders, $42.7bn
Q3 20227 holders, $802m31 holders, $43.4bn
Q4 20227 holders, $872m31 holders, $46.6bn
Q1 20236 holders, $883m33 holders, $44.3bn
Q2 20236 holders, $919m37 holders, $59.6bn
Q3 20235 holders, $550m44 holders, $67.6bn
Q4 20239 holders, $516m45 holders, $73.6bn
Q1 202410 holders, $569m41 holders, $95.3bn
Q2 202410 holders, $627m43 holders, $110bn
Q3 202411 holders, $895m45 holders, $107bn
Q4 202411 holders, $670m46 holders, $93.9bn
Q1 202510 holders, $490m42 holders, $98.4bn
Q2 20256 holders, $495m43 holders, $93.2bn
Q3 20255 holders, $527m39 holders, $86.7bn
Q4 20256 holders, $533m41 holders, $123bn
Q1 20264 holders, $428m39 holders, $106bn
Q2 20264 holders, $502m44 holders, $132bn
ICUI

Icu Med Inc

Holders
4
Reported value
$428m
Buyers
9
Sellers
12

Breadth -3 among 91 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
39
Reported value
$106bn
Buyers
25
Sellers
25

Breadth 0 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2026

Among the 39 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ICUI (0)

None.

Only LLY (35)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, ARK Investment Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Marshall Wace LLP, Millennium Management LLC, Point72 Asset Management LP, Polen Capital Management LLC, and 10 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →